This is the current revision of this page, as edited by Buidhe (talk | contribs) at 20:34, 1 December 2023 (Removing from Category:Monoclonal antibodies using Cat-a-lot). The present address (URL) is a permanent link to this version.
Revision as of 20:34, 1 December 2023 by Buidhe (talk | contribs) (Removing from Category:Monoclonal antibodies using Cat-a-lot)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Monoclonal antibody Pharmaceutical compound| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | rabies virus glycoprotein |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C6400H9914N1718O1998S44 |
| Molar mass | 144304.38 g·mol |
| (what is this?) (verify) | |
Foravirumab is a monoclonal antibody for the prophylaxis of rabies. It is under development by Sanofi/Crucell.
References
- International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- Khardori NM (2011). Biologic Response Modifiers in Infectious Diseases, An Issue of Infectious Disease Clinics. London: Elsevier Health Sciences. p. 158. ISBN 978-1-4557-1207-6.
| Monoclonal antibodies for infectious disease and toxins | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Fungal |
| ||||||||
| Viral | |||||||||
| Bacterial |
| ||||||||
| Toxin |
| ||||||||
| |||||||||
 | This antiinfective drug article is a stub. You can help Misplaced Pages by expanding it. |
 | This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it. |